Trial NCT05060276

View at ClinicalTrials.gov 
Org. Study IDs: T2ADC-RRST-101

Last trial update was posted on 2023-01-26

MeSH Interventions

Immunoconjugates

MeSH Conditions

Neoplasms

Other Conditions

Refractory Cancer Relapsed Solid Neoplasm Solid Tumor, Adult

Stopping Reasons

Protocol changed to Phase 2

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID